Q32 Bio (QTTB) EBIT Margin (2018 - 2023)

Q32 Bio (QTTB) posted quarterly EBIT Margin of 1897.72% for Q4 2023, up 619872.0% year-over-year from N/an in Q4 2022, and up 552.41% quarter-over-quarter from 419.47% in Q3 2023.

Q32 Bio (QTTB) EBIT Margin (2018 - 2023) Analysis & Trends

Q32 Bio's EBIT Margin history runs 6 years deep, the most recent figure standing at 1897.72% for Q4 2023.

  • In Q4 2023, EBIT Margin rose 619872.0% year-over-year to 1897.72%; the TTM figure through Sep 2024 stood at 5690.07% (up 633616.0% YoY), while the FY2025 annual figure was 31.45%, changed N/A from the prior year.
  • EBIT Margin for Q4 2023 stood at 1897.72%, up from 419.47% in the prior quarter.
  • The five-year high for EBIT Margin was 1897.72% in Q4 2023, with the low at 9304.81% in Q1 2019.
  • The 5-year median for EBIT Margin is 4145.07% (2021), against an average of 3582.2%.
  • The sharpest annual moves came in 2019 and 2021: EBIT Margin plunged 835743 bps in 2019, then soared 620233 bps in 2021.
  • Q32 Bio's EBIT Margin stood at 4539.79% in 2019, then surged by 33 bps to 3041.02% in 2020, then slumped by 38 bps to 4192.64% in 2021, then retreated by 3 bps to 4301.0% in 2022, then surged by 144 bps to 1897.72% in 2023.
  • Business Quant data shows QTTB's EBIT Margin at 1897.72% in Q4 2023, 419.47% in Q3 2023, and 226.99% in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.15%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 31.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 19.06%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -105.20%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 19.75%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 17.93%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.36%
10 Q32 Bio 359.61 Mn 253.31 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1,897.72%
Sep 30, 2023 -419.47%
Jun 30, 2023 -226.99%
Mar 31, 2023 -250.19%
Dec 31, 2022 -4,301.00%
Sep 30, 2022 -4,097.51%
Jun 30, 2022 -3,529.55%
Mar 31, 2022 -4,690.52%
Dec 31, 2021 -4,192.64%
Sep 30, 2021 -1,828.32%
Jun 30, 2021 -1,396.98%
Mar 31, 2021 -3.79%
Dec 31, 2020 -3,041.02%
Sep 30, 2020 -4,986.42%
Jun 30, 2020 -6,295.77%
Mar 31, 2020 -6,206.12%
Dec 31, 2019 -4,539.79%
Sep 30, 2019 -7,094.78%
Jun 30, 2019 -7,135.97%
Mar 31, 2019 -9,304.81%